Ableads
Develops personalized therapeutic antibodies for cancer patients with tumors that have low mutation rates
Highlights
- New on EvolcAdded 2026-11-13
About Ableads
AbLeads is developing personalized therapeutic antibodies using its Dualock Display technology to activate immune detection of tumors with low mutational profiles.
The company operates in cancer immunotherapy and presents its work to biotech, pharmaceutical, clinical and academic audiences. It is based in Pessac, France, and was founded in 2017.
Product: Personalized therapeutic antibodies for cancer immunotherapy, developed using its Dualock Display technology.
Jobs at Ableads
More biotech & pharma companies
Aboleris Pharma
Develops immune-tolerance therapies for patients with autoimmune diseases and organ transplant rejectionNew on EvolcActicor Biotech
Clinical-stage biopharma developing glenzocimab, an antithrombotic antibody fragment for acute ischemic stroke patientsNew on EvolcActiv-H
Superacid flow chemistry R&D services for pharmaceutical and biotech drug discovery teamsYoung companyNew on EvolcAdcytherix
Develops antibody-drug conjugate cancer therapies for patients with cancers resistant to current treatmentsYoung companyNew on EvolcAdemtech
Magnetic particles and molecular diagnostic kits for IVD, life sciences and forensic laboratoriesAdhexpharma
Develops and manufactures pharmaceutical patches and oral films for pharmaceutical and biotechnology companies
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
- Response headerx-powered-by
- Response headerx-powered-by
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- ReactHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Payments
- StripeHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.